Synopsis of Social media discussions

The discussions reveal a consensus that the AFFIRM trial established no significant survival benefit between rate and rhythm control, with examples like references to the trial’s findings and mentions of adverse events. The tone is informative and analytical, emphasizing clinical significance and historical context, which supports the overall high engagement and interest levels.

A
Agreement
Moderate agreement

Most discussions acknowledge the findings of the study, especially referencing the AFFIRM trial and its conclusion that both strategies are comparable, with some posts emphasizing no survival benefit of rhythm control.

I
Interest
High level of interest

Many posts show active engagement with the topic, discussing historical context, trial results, and clinical implications, indicating high interest.

E
Engagement
High engagement

Users are deep in the discussion, citing specific trials, methodologies, and clinical implications, demonstrating a strong level of engagement.

I
Impact
Moderate level of impact

The discussions could influence clinical perspectives on AF management strategies, but primarily within medical communities; thus, the perceived impact is moderate.

Social Mentions

YouTube

5 Videos

Twitter

34 Posts

Blogs

12 Articles

News

14 Articles

Metrics

Video Views

202,959

Total Likes

2,790

Extended Reach

377,003

Social Features

65

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Comparison of Rate and Rhythm Control in Atrial Fibrillation Treatment

Comparison of Rate and Rhythm Control in Atrial Fibrillation Treatment

This video discusses a study comparing two treatment strategies for atrial fibrillation: rhythm control to restore normal heart rhythm, and rate control to manage heart rate while AF persists. Both strategies include anticoagulation to prevent strokes.

November 27, 2018

189,897 views


Choosing Rate vs Rhythm Control for Atrial Fibrillation

Choosing Rate vs Rhythm Control for Atrial Fibrillation

This Harvard Medical School video addresses how to choose rate vs rhythm control for atrial fibrillation patients. Dr. William Hucker highlights rising AF rates and treatment options, emphasizing early intervention benefits shown in recent studies, including reduced cardiovascular risks.


Rate versus rhythm control in atrial fibrillation: a comprehensive comparison

Rate versus rhythm control in atrial fibrillation: a comprehensive comparison

This video discusses a study comparing rate control and rhythm control strategies for atrial fibrillation. The results show no significant difference in survival rates, with rhythm control leading to more hospitalizations and adverse effects.

July 1, 2025

1,449 views


Current Advances in Atrial Fibrillation Treatment and Endurance Athlete Cardiac Risks

Current Advances in Atrial Fibrillation Treatment and Endurance Athlete Cardiac Risks

This week in cardiology discusses the VENTOUX study on endurance athletes and arrhythmias, the ongoing debate between rate and rhythm control in atrial fibrillation, and the role of GLP1 drugs. The importance of anticoagulation in stroke prevention is also highlighted.

July 25, 2025

536 views


Treatment Strategies for Atrial Fibrillation: Rate vs Rhythm Control

Treatment Strategies for Atrial Fibrillation: Rate vs Rhythm Control

This video examines differences in treatment approaches for atrial fibrillation, comparing rate control and rhythm control strategies. It discusses their impact on patient outcomes, hospitalizations, and the importance of anticoagulation in stroke prevention.

February 12, 2024

29 views


  • Mohammad Aleidi
    @aleidimed (Twitter)

    RT @Basalus: 2/ AF management has two main strategies: •Rate control: manage heart rate •Rhythm control: restore & maintain sinus rhythm H…
    view full post

    April 7, 2025

  • Mounir Basalus (Ⲃⲁⲥⲓⲗⲓⲟⲥ)
    @Basalus (Twitter)

    2/ AF management has two main strategies: •Rate control: manage heart rate •Rhythm control: restore & maintain sinus rhythm Historically, both were considered equivalent (AFFIRM trial, 2002). But the landscape has changed. [https://t.co/ky8HlooyoA]
    view full post

    April 6, 2025

    4

  • 色々自粛中(ガラス細工の様な繊細なハートを持つ貴公子
    @ECGEPSCADEVICE (Twitter)

    RT @matsu58328: A comparison of rate control and rhythm control in patients with atrial fibrillation https://t.co/R6cwVAPE11
    view full post

    May 18, 2024

    1

  • matsuneko
    @matsu58328 (Twitter)

    A comparison of rate control and rhythm control in patients with atrial fibrillation https://t.co/R6cwVAPE11
    view full post

    May 18, 2024

    2

    1

  • 色々自粛中(ガラス細工の様な繊細なハートを持つ貴公子
    @ECGEPSCADEVICE (Twitter)

    RT @tororo__ph:
    view full post

    September 29, 2022

    1

  • Tororo_ph@EP Univ. oshademic
    @tororo__ph (Twitter)


    view full post

    September 29, 2022

    5

    1

  • Branden Engorn
    @BrandenEngorn (Twitter)

    RT @EMARIANOMD: Excellent discussion by @MSharifpourMD about managing perioperative atrial fibrillation #CSAAnnual22 Cites AFFIRM trial h…
    view full post

    April 8, 2022

    5

  • Rita “Proudly Vaccinated” Agarwal MD
    @Ritaagarwal6 (Twitter)

    RT @EMARIANOMD: Excellent discussion by @MSharifpourMD about managing perioperative atrial fibrillation #CSAAnnual22 Cites AFFIRM trial h…
    view full post

    April 8, 2022

    5

  • John W. Patton III, MD, MBA
    @drjohnpatton (Twitter)

    RT @EMARIANOMD: Excellent discussion by @MSharifpourMD about managing perioperative atrial fibrillation #CSAAnnual22 Cites AFFIRM trial h…
    view full post

    April 8, 2022

    5

  • Juan G. Ripoll, MD
    @JuanGRipoll1 (Twitter)

    RT @EMARIANOMD: Excellent discussion by @MSharifpourMD about managing perioperative atrial fibrillation #CSAAnnual22 Cites AFFIRM trial h…
    view full post

    April 8, 2022

    5

  • Milad Sharifpour, MD
    @MSharifpourMD (Twitter)

    RT @EMARIANOMD: Excellent discussion by @MSharifpourMD about managing perioperative atrial fibrillation #CSAAnnual22 Cites AFFIRM trial h…
    view full post

    April 8, 2022

    5

  • Adrian Soto-Mota
    @AdrianSotoMota (Twitter)

    El estudio clásico es el AFFIRM: ¿Control de ritmo o control de foco en pacientes con fibrilación auricular? https://t.co/nsGk36T70X
    view full post

    January 31, 2022

    5


  • @koureiigaku (Twitter)

    また過去の報告*では慢性化した心房細動患者を対象に洞調律化療法を評価していますが、本試験では早期心房細動患者を対象に診断直後の洞調律化療法を評価しまた参加者の54%が登録時に洞調律でした。 https://t.co/KX0B5xfuqh https://t.co/4I1cYUHW2N https://t.co/5mWmM6wNca https://t.co/Iwirfb16GQ
    view full post

    January 10, 2021


  • @koureiigaku (Twitter)

    過去に洞調律化療法は心拍数管理よりも良い転帰を示さなかったと報告*されています。 https://t.co/KX0B5xfuqh https://t.co/4I1cYUHW2N https://t.co/5mWmM6wNca https://t.co/Iwirfb16GQ
    view full post

    January 8, 2021


  • @koureiigaku (Twitter)

    本試験において早期洞調律化療法は入院日数に影響しておらず、過去の2つの大規模試験*で洞調律化療法による入院日数増加が報告されていることを考慮すると、本試験の結果には期待が持てます。 https://t.co/4I1cYUHW2N https://t.co/Wm5q6bzrxw
    view full post

    January 7, 2021


  • @koureiigaku (Twitter)

    抗凝固療法による最大限の心房細動関連脳塞栓症予防*や心拍数管理による症状緩和を行っても*も前述の合併症は発生してしまいます。 https://t.co/MzgVjJiBDG https://t.co/4I1cYUHW2N
    view full post

    December 22, 2020

  • Dr. Márcio Figueiredo EP
    @figueiredo_ep (Twitter)

    RT @CardioSmart: (6/11) #AFibAwareness #Tweetorial: The AFFIRM study compared rhythm & rate control. Rhythm control= cardioversion & antia…
    view full post

    September 12, 2020

    5

  • CVC
    @CVC_Adelaide (Twitter)

    RT @CardioSmart: (6/11) #AFibAwareness #Tweetorial: The AFFIRM study compared rhythm & rate control. Rhythm control= cardioversion & antia…
    view full post

    September 12, 2020

    5

  • Prash Sanders
    @PrashSanders (Twitter)

    RT @CardioSmart: (6/11) #AFibAwareness #Tweetorial: The AFFIRM study compared rhythm & rate control. Rhythm control= cardioversion & antia…
    view full post

    September 12, 2020

    5

  • Rakesh Gopinath
    @drrakeshg1 (Twitter)

    RT @CardioSmart: (6/11) #AFibAwareness #Tweetorial: The AFFIRM study compared rhythm & rate control. Rhythm control= cardioversion & antia…
    view full post

    September 12, 2020

    5

  • DJ Lakkireddy
    @DJ_Lakkireddy (Twitter)

    RT @CardioSmart: (6/11) #AFibAwareness #Tweetorial: The AFFIRM study compared rhythm & rate control. Rhythm control= cardioversion & antia…
    view full post

    September 12, 2020

    5

  • CardioSmart
    @CardioSmart (Twitter)

    (6/11) #AFibAwareness #Tweetorial: The AFFIRM study compared rhythm & rate control. Rhythm control= cardioversion & antiarrhythmic
    view full post

    September 12, 2020

    9

    5

  • Abdulaziz ALHAZMI عبدالعزيز الحازمي
    @drhazmi_6 (Twitter)

    RT @journalclubju: #Journal_Club_JU اللقاء السادس والأخير للدورة الأولى من دورات الجورنال كلوب عنوان المقالة : A COMPARISON OF RATE CON…
    view full post

    July 15, 2020

    8

  • Ahmad Alharbi أحمد بن علي
    @ahmadalharbi12 (Twitter)

    RT @journalclubju: #Journal_Club_JU اللقاء السادس والأخير للدورة الأولى من دورات الجورنال كلوب عنوان المقالة : A COMPARISON OF RATE CON…
    view full post

    July 14, 2020

    8

  • نادي الطب
    @JU_MedClub (Twitter)

    RT @journalclubju: #Journal_Club_JU اللقاء السادس والأخير للدورة الأولى من دورات الجورنال كلوب عنوان المقالة : A COMPARISON OF RATE CON…
    view full post

    July 14, 2020

    8

  • Medicine Club
    @JUMedClub (Twitter)

    RT @journalclubju: #Journal_Club_JU اللقاء السادس والأخير للدورة الأولى من دورات الجورنال كلوب عنوان المقالة : A COMPARISON OF RATE CON…
    view full post

    July 14, 2020

    8

  • عبدالله
    @AOT_21 (Twitter)

    RT @journalclubju: #Journal_Club_JU اللقاء السادس والأخير للدورة الأولى من دورات الجورنال كلوب عنوان المقالة : A COMPARISON OF RATE CON…
    view full post

    July 14, 2020

    8

  • إيهاب الأمير
    @Ehab_Alameer (Twitter)

    RT @journalclubju: #Journal_Club_JU اللقاء السادس والأخير للدورة الأولى من دورات الجورنال كلوب عنوان المقالة : A COMPARISON OF RATE CON…
    view full post

    July 14, 2020

    8

  • Mohammed Alharbi
    @DR_MO44 (Twitter)

    RT @journalclubju: #Journal_Club_JU اللقاء السادس والأخير للدورة الأولى من دورات الجورنال كلوب عنوان المقالة : A COMPARISON OF RATE CON…
    view full post

    July 14, 2020

    8

  • Journal Club
    @journalclubju (Twitter)

    #Journal_Club_JU اللقاء السادس والأخير للدورة الأولى من دورات الجورنال كلوب عنوان المقالة : A COMPARISON OF RATE CONTROL AND RHYTHM CONTROL IN PATIENTS WITH ATRIAL FIBRILLATION الطب الباطني- تخصص أمراض القلب https://t.co/njuNuASWh7
    view full post

    July 14, 2020

    13

    8

  • د.شعلان العامري
    @ShalanAlaamri (Twitter)

    @drmoutaz ( AFFIRM trial ): In patients with nonvalvular AF, there is no survival benefit between rate and rhythm control, rate-control resulted in a lower incidence of adverse events https://t.co/ehA06NDtzt
    view full post

    May 27, 2020

    3

  • .┓┏.
    @whisperofgecko (Twitter)

    RT @Vannyamoto: A comparison of rate control and rhythm control in patients with atrial fibrillation. - PubMed - NCBI AFFIRM試験 心房細動に対するレー…
    view full post

    April 13, 2019

    1

  • 猫になりたい薬剤師
    @Vannyamoto (Twitter)

    A comparison of rate control and rhythm control in patients with atrial fibrillation. - PubMed - NCBI AFFIRM試験 心房細動に対するレート vs. リズム 死亡率に差はないが,副作用の観点からレートコントロールの方が良いのではないか,という研究結果 https://t.co/FfbFjuhf4u
    view full post

    April 13, 2019

    7

    1

  • Leland Stillman, MD
    @StillmanMD (Twitter)

    This #Aprilfoolsday remember that sometimes #doctors make big mistakes that they only figure out once the mortality trends are clear i.e. lots of people have died. The only cure for a bad environment is to change it. #naturecures Drugs = band aids https://t.co/CYoQHWgIYO
    view full post

    April 1, 2019

    3

Abstract Synopsis

  • The study compared two treatment strategies for atrial fibrillation: rhythm control, which aims to restore normal heart rhythm, and rate control, which allows AF to persist but manages heart rate, with anticoagulants used in both.
  • Results showed no significant survival benefit of rhythm control over rate control over five years, with mortality rates of 23.8% and 21.3%, respectively.
  • Patients on rhythm control experienced more hospitalizations and adverse drug effects, and anticoagulation remains crucial in both groups to prevent strokes, especially when warfarin levels are not well-controlled.]